Results 271 to 280 of about 1,509,178 (304)
Some of the next articles are maybe not open access.

Protective role of endothelial nitric oxide synthase

The Journal of Pathology, 2002
AbstractNitric oxide is a versatile molecule, with its actions ranging from haemodynamic regulation to anti‐proliferative effects on vascular smooth muscle cells. Nitric oxide is produced by the nitric oxide synthases, endothelial NOS (eNOS), neural NOS (nNOS), and inducible NOS (iNOS).
Ester W J A, Albrecht   +4 more
openaire   +2 more sources

THE REGULATION AND PHARMACOLOGY OF ENDOTHELIAL NITRIC OXIDE SYNTHASE

Annual Review of Pharmacology and Toxicology, 2006
▪ Abstract  Nitric oxide (NO) is a small, diffusible, lipophilic free radical gas that mediates significant and diverse signaling functions in nearly every organ system in the body. The endothelial isoform of nitric oxide synthase (eNOS) is a key source of NO found in the cardiovascular system.
David M, Dudzinski   +3 more
openaire   +2 more sources

Endothelial nitric oxide synthase polymorphisms and hypertension

Current Hypertension Reports, 2003
The human endothelial nitric oxide synthase (eNOS) gene is highly polymorphic. Evidence for the involvement of eNOS single nucleotide polymorphisms in the development of essential hypertension is limited, though the eNOS Glu298Asp polymorphism appears to influence the blood pressure response to exercise.
openaire   +2 more sources

Endothelial nitric oxide synthase and LTP

Nature, 1997
R I, Wilson   +5 more
openaire   +2 more sources

ENDOTHELIAL NITRIC OXIDE SYNTHASE

Medicine & Science in Sports & Exercise, 2001
T K. Smith   +4 more
openaire   +1 more source

Endothelial Nitric Oxide Synthase

2007
Hartmut Kleinert, Ulrich Forstermann
openaire   +1 more source

Oxidative Stress, GTPCH1, and Endothelial Nitric Oxide Synthase Uncoupling in Hypertension

Antioxidants and Redox Signaling, 2021
Tharmarajan Ramprasath, Ming-Hui Zou
exaly  

Therapeutic Implications of Human Endothelial Nitric Oxide Synthase Gene Polymorphism

Trends in Pharmacological Sciences, 2001
Anthony P Young   +2 more
exaly  

Epigenetics of Cardiovascular Disease: A New ‘Beat' in Coronary Artery Disease

Medical Epigenetics, 2014
Paul J Turgeon   +2 more
exaly  

Home - About - Disclaimer - Privacy